FXI Falls as US-China Tensions Keep Pressure

The latest backdrop is not a single event but a widening web of pressure. The EU trade chief has arrived in China to try to ease economic strains and avoid a broader trade war, while Beijing continues to criticize unilateral US measures. At the same time, North Korea’s condemnation of US arms sales to Taiwan and ballistic missile launches underline how the Taiwan issue remains a live geopolitical fault line. For markets, that combination is toxic: it lifts policy risk, complicates supply chains and keeps a ceiling on cross-border capital flows.

You can see the risk premium elsewhere. The dollar ETF UUP has climbed to 29.02 and is trading above both its 50-day and 200-day averages, a sign that investors still want the safety of US assets when geopolitics gets louder. SPY, meanwhile, remains near record territory at 778.57, showing that global investors are still comfortable owning US equities even as they hedge uncertainty through the currency market rather than abandoning risk entirely.

That split is important. The market is not saying the confrontation will become a crisis tomorrow. It is saying the cost of doing business across the US-China divide is rising, and that cost is showing up in valuations, in capital allocation and in the names most exposed to mainland demand. FXI’s weak relative trend suggests investors are still reluctant to pay up for China rerating without a clearer thaw in trade, technology and security relations.

Our thesis is that this remains an underappreciated setup for selective positioning rather than blanket risk-taking. If tensions stay elevated, the beneficiaries are not the obvious China beta trades but the companies and sectors that sit further up the value chain: US industrials tied to reshoring, defense names tied to Indo-Pacific security, and dollar-linked assets that gain when uncertainty persists. If talks eventually improve, the rebound could be sharp — but the market is not there yet.

For now, the trade is simple: respect the geopolitical premium, stay selective on China exposure, and treat any durable easing in US-China tensions as a catalyst, not a baseline.